Cover Image
Market Research Report

Sustained Release Injectables to 2024

Published by Greystone Research Associates Product code 672887
Published Content info 190 Pages
Delivery time: 1-2 business days
Price
Back to Top
Sustained Release Injectables to 2024
Published: August 9, 2018 Content info: 190 Pages
Description

Improved drug formulation tech-nology and sophisticated injection deices are converging to create opportunities for sustained release dosing. The ability to formulate injectable drugs to increase the duration of efficacy for a given dose and simultaneously reduce the dosing frequency addresses several important health care issues. Less frequent dosing is believed to improve patient safety, reduce the incidence of injection site complications and improve com-pliance with drug protocols. Sustained release formulations mitigate the bolus effect at the time of injection, and thus have a salutary influence on drug side effects.

Sustained Release Injectables - What You Will Learn

  • What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
  • What are the major factors driving sustained release injectable drug demand?
  • What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
  • How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
  • What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
  • In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
  • What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?
Table of Contents
Product Code: SRJ223F

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Trend toward Self-Administration
  • Injectable Drug Formulation Technology
  • Innovation in Injectable Device Designs
  • Therapeutic Demand Drivers
  • Market Factors
  • Competitive Landscape
  • Risk Factors

Sustained Release Formulation Technologies

  • Biodegradable Polymers
  • Branded SR Formulation Technologies
  • Physical Process Control Methods

Sustained Release Injectables - Development Factors

  • Formulation Factors
  • Stability
  • Lyophilization
  • Packaging
  • Administration Factors

The Sustained Release Product Landscape

  • Alkaloids
  • Anesthetics
  • Antineoplastics
  • GnRH Agonists
  • Opioid Antagonists
  • Synthetic Peptides
  • Cytokines
  • Hormones
  • Antipsychotics
  • Other Drug Classes

Development-stage SR Injectables

SR Injectables - Therapeutic Market Sector Analysis & Forecasts

  • Addiction
  • Endocrinology
  • Glycemic Control
  • Infectious Disease
  • Hormone Deficiency
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Leukemia
  • Lymphoma
  • Prostate
  • Pain Management
  • Reproductive Health

Company Profiles

Back to Top